Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Novel Antimurine Thyroid-Stimulating Hormone Receptor Monoclonal Antibodies.
Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy
Published: June 21, 2023
The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy.
Journal: Frontiers in immunology
Published: June 09, 2023
Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo.
Journal: Science advances
Published: December 08, 2022
Emerging concepts in PD-1 checkpoint biology.
Journal: Seminars in immunology
Published: April 29, 2021
Cost-effectiveness of immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer.
Journal: Cancer
Published: April 14, 2018
Targeting lymphoma with precision using semisynthetic anti-idiotype peptibodies.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 27, 2016
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors.
Journal: The Journal of clinical investigation
Published: May 17, 2012
Showing 1-7 of 7
Last Updated: 09/26/2026